Imidazolidinyl vanillic acid ether derivatives and their uses

Imidazolidinyl vanillic acid ether derivatives with structural modifications improve antiplatelet aggregation and bioavailability, effectively treating thrombotic diseases like myocardial infarction and stroke.

JP7883729B2Active Publication Date: 2026-07-02HEFEI INDUSTRIAL PHARMACEUTICAL INSTITUTE CO LTD +1
6 Cites 0 Cited by

Patent Information

Application Number
JP2024573328
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-06-13
Publication Date
2026-07-02
Estimated Expiration
2042-06-13

Smart Images

  • Figure 0007883729000001
    Figure 0007883729000001
  • Figure 0007883729000002
    Figure 0007883729000002
  • Figure 0007883729000003
    Figure 0007883729000003
Patent Text Reader

Abstract

The present invention provides an imidazolidinyl vanillic acid ether derivative represented by formula (I) and its use. The imidazolidinyl vanillic acid ether derivative of formula (I) according to the present invention has higher in vivo bioavailability and in vivo antiplatelet aggregation activity compared to the prior art, and is useful for the treatment and / or prevention of thromboembolic-related diseases. 【Chemical 1】 JPEG2025518969000037.jpg31170
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Imidazole ethyl vanillic acid ether, preparation method and medicinal application thereof

    CN101851209A

  • Nn*phenoxyalkyl*imidazole compound

    JP1980085572A

  • Novel 2-hydroxybenzoic acid imidazoles and manufacture

    JP1985112773A

  • Imidazolylphenol derivative, medicine containing it, and method of producing said compound and said medicine

    JP1994009571A

  • Compounds for treating paramyxovirus infections

    JP2015531769A